Yizhou Dong
Title
Cited by
Cited by
Year
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
H Yin, CQ Song, JR Dorkin, LJ Zhu, Y Li, Q Wu, A Park, J Yang, S Suresh, ...
Nature biotechnology 34 (3), 328-333, 2016
5232016
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
JE Dahlman, C Barnes, OF Khan, A Thiriot, S Jhunjunwala, TE Shaw, ...
Nature nanotechnology 9 (8), 648-655, 2014
4312014
Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery
Z Gu, TT Dang, M Ma, BC Tang, H Cheng, S Jiang, Y Dong, Y Zhang, ...
ACS nano 7 (8), 6758-6766, 2013
2792013
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates (vol 111, pg 3955, 2014)
Y Dong, KT Love, JR Dorkin, S Sirirungruang, Y Zhang, D Chen, ...
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF …, 2014
263*2014
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Y Dong, KT Love, JR Dorkin, S Sirirungruang, Y Zhang, D Chen, ...
Proceedings of the National Academy of Sciences 111 (11), 3955-3960, 2014
2632014
Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation
D Chen, KT Love, Y Chen, AA Eltoukhy, C Kastrup, G Sahay, A Jeon, ...
Journal of the American Chemical Society 134 (16), 6948-6951, 2012
2612012
Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents
Y Dong, SL Morris-Natschke, KH Lee
Natural product reports 28 (3), 529-542, 2011
1672011
A non-viral CRISPR/Cas9 delivery system for therapeutic gene targeting in vivo
C Jiang, M Mei, B Li, X Zhu, W Zu, Y Tian, Q Wang, Y Guo, Y Dong, X Tan
Cell Research, 2017
122*2017
A highly efficient and direct approach for synthesis of enantiopure β-amino alcohols by reductive cross-coupling of chiral N-tert-Butanesulfinyl imines with aldehydes
YW Zhong, YZ Dong, K Fang, K Izumi, MH Xu, GQ Lin
Journal of the American Chemical Society 127 (34), 11956-11957, 2005
1192005
An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo
B Li, X Luo, B Deng, J Wang, DW McComb, Y Shi, KML Gaensler, X Tan, ...
Nano letters 15 (12), 8099-8107, 2015
722015
Dendrimer-inspired nanomaterials for the in vivo delivery of siRNA to lung vasculature
OF Khan, EW Zaia, S Jhunjhunwala, W Xue, W Cai, DS Yun, CM Barnes, ...
Nano letters 15 (5), 3008-3016, 2015
712015
Antitumor agents. 266. Design, synthesis, and biological evaluation of novel 2-(furan-2-yl) naphthalen-1-ol derivatives as potent and selective antibreast cancer agents
Y Dong, Q Shi, YN Liu, X Wang, KF Bastow, KH Lee
Journal of medicinal chemistry 52 (11), 3586-3590, 2009
712009
Injectable and Glucose-Responsive Hydrogels Based on Boronic Acid–Glucose Complexation
Y Dong, W Wang, O Veiseh, EA Appel, K Xue, MJ Webber, BC Tang, ...
Langmuir 32 (34), 8743-8747, 2016
652016
Antitumor agents. 272. Structure− Activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues
Y Dong, Q Shi, HC Pai, CY Peng, SL Pan, CM Teng, K Nakagawa-Goto, ...
Journal of medicinal chemistry 53 (5), 2299-2308, 2010
632010
Two-Photon Near Infrared Fluorescent Turn-On Probe Toward Cysteine and Its Imaging Applications
J Wang, B Li, W Zhao, X Zhang, X Luo, ME Corkins, SL Cole, C Wang, ...
ACS Sensors 1 (7), 882-887, 2016
622016
Design, synthesis, and preclinical evaluation of new 5, 6-(or 6, 7-) disubstituted-2-(fluorophenyl) quinolin-4-one derivatives as potent antitumor agents
LC Chou, MT Tsai, MH Hsu, SH Wang, TD Way, CH Huang, HY Lin, ...
Journal of medicinal chemistry 53 (22), 8047-8058, 2010
602010
Poly (glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo
Y Dong, JR Dorkin, W Wang, PH Chang, MJ Webber, BC Tang, J Yang, ...
Nano letters 16 (2), 842-848, 2016
562016
Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
Y Dong, KT Love, RS Langer, DG Anderson, D Chen, Y Chen, AJ Vegas, ...
US Patent 9,512,073, 2016
502016
Effects of Chemically Modified Messenger RNA on Protein Expression
B Li, X Luo, Y Dong
Bioconjugate chemistry 27 (3), 849-853, 2016
502016
Antitumor agents 278. 4-Amino-2H-benzo [h] chromen-2-one (ABO) analogs as potent in vitro anti-cancer agents
Y Dong, K Nakagawa-Goto, CY Lai, SL Morris-Natschke, KF Bastow, ...
Bioorganic & medicinal chemistry letters 20 (14), 4085-4087, 2010
442010
The system can't perform the operation now. Try again later.
Articles 1–20